{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:51:55Z","timestamp":1786121515587,"version":"build-2736575974"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100017540","name":"National Heart Lung and Blood Institute Division of Intramural Research","doi-asserted-by":"publisher","award":["P01 HL152960"],"award-info":[{"award-number":["P01 HL152960"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"National Heart Lung and Blood Institute Division of Intramural Research","doi-asserted-by":"publisher","award":["P01 HL172740"],"award-info":[{"award-number":["P01 HL172740"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"National Heart Lung and Blood Institute Division of Intramural Research","doi-asserted-by":"publisher","award":["P01 HL091842"],"award-info":[{"award-number":["P01 HL091842"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001024","name":"Roy J Carver Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["STOLTZ23R0"],"award-info":[{"award-number":["STOLTZ23R0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jcf.2026.07.1985","type":"journal-article","created":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T18:57:55Z","timestamp":1785697075000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antiviral defenses are diminished at birth in cystic fibrosis pig airways"],"prefix":"10.1016","author":[{"given":"Jennifer A.","family":"Bartlett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel E.","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda S.","family":"Powers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine L.","family":"Wohlford-Lenane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla E.","family":"Hippee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Marquez Loza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin W.","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brajesh K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel I.","family":"Sands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Huntemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley L.","family":"Cooney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark P.","family":"Rogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford C.","family":"Taggart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David K.","family":"Meyerholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Paul B.","family":"McCray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jcf.2026.07.1985_bib0001","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.3390\/ijms26062636","article-title":"Innate immunity in cystic fibrosis: varied effects of CFTR modulator therapy on cell-to-cell communication","volume":"26","author":"Hynes","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.jcf.2026.07.1985_bib0002","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3390\/cells11071243","article-title":"CFTR modulator therapies: potential impact on airway infections in cystic fibrosis","volume":"11","author":"Saluzzo","year":"2022","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.jcf.2026.07.1985_bib0003","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/ppul.25859","article-title":"A survey: understanding the health and perspectives of people with CF not benefiting from CFTR modulators","volume":"57","author":"Kramer-Golinkoff","year":"2022","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"10.1016\/j.jcf.2026.07.1985_bib0004","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1055\/s-0042-1758728","article-title":"Respiratory viruses and cystic fibrosis","volume":"44","author":"Brackenborough","year":"2023","journal-title":"Semin Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.jcf.2026.07.1985_bib0005","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijpam.2019.09.003","article-title":"The prevalence of viral infections in children with cystic fibrosis in a tertiary care center in Saudi Arabia","volume":"7","author":"Banjar","year":"2020","journal-title":"Int J Pediatr Adolesc Med"},{"issue":"11","key":"10.1016\/j.jcf.2026.07.1985_bib0006","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1136\/thx.51.11.1115","article-title":"Effects of upper respiratory tract infections in patients with cystic fibrosis","volume":"51","author":"Collinson","year":"1996","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.jcf.2026.07.1985_bib0007","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jcf.2019.02.004","article-title":"Early respiratory viral infections in infants with cystic fibrosis","volume":"18","author":"Deschamp","year":"2019","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.jcf.2026.07.1985_bib0008","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/thoraxjnl-2013-204000","article-title":"Incidence and clinical impact of respiratory viruses in adults with cystic fibrosis","volume":"69","author":"Flight","year":"2014","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.jcf.2026.07.1985_bib0009","doi-asserted-by":"crossref","first-page":"549","DOI":"10.24953\/turkjped.2020.1926","article-title":"El-Attar MM. Is there a role of viral infection in cystic fibrosis exacerbation in children?","volume":"64","author":"Hamed","year":"2022","journal-title":"Turk J Pediatr"},{"issue":"5","key":"10.1016\/j.jcf.2026.07.1985_bib0010","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1651-2227.1981.tb05757.x","article-title":"Respiratory infections in cystic fibrosis patients caused by virus, chlamydia and mycoplasma\u2013possible synergism with Pseudomonas aeruginosa","volume":"70","author":"Petersen","year":"1981","journal-title":"Acta Paediatr Scand"},{"issue":"12","key":"10.1016\/j.jcf.2026.07.1985_bib0011","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1093\/cid\/cix203","article-title":"Cystic fibrosis pulmonary exacerbations attributable to Respiratory syncytial virus and influenza: a population-based study","volume":"64","author":"Somayaji","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"26","key":"10.1016\/j.jcf.2026.07.1985_bib0012","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJM198412273112602","article-title":"Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis","volume":"311","author":"Wang","year":"1984","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jcf.2026.07.1985_bib0013","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/(SICI)1099-0496(199812)26:6<371::AID-PPUL1>3.0.CO;2-N","article-title":"Severe viral respiratory infections in infants with cystic fibrosis","volume":"26","author":"Armstrong","year":"1998","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"10.1016\/j.jcf.2026.07.1985_bib0014","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1542\/peds.103.3.619","article-title":"Effects of viral lower respiratory tract infection on lung function in infants with cystic fibrosis","volume":"103","author":"Hiatt","year":"1999","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.jcf.2026.07.1985_bib0015","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1378\/chest.12-0954","article-title":"High rhinovirus burden in lower airways of children with cystic fibrosis","volume":"143","author":"Kieninger","year":"2013","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.jcf.2026.07.1985_bib0016","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1542\/peds.2007-3139","article-title":"Prevalence and impact of respiratory viral infections in young children with cystic fibrosis: prospective cohort study","volume":"122","author":"van Ewijk","year":"2008","journal-title":"Pediatrics"},{"issue":"11","key":"10.1016\/j.jcf.2026.07.1985_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143129","article-title":"Rhinovirus load is high despite preserved interferon-beta response in cystic fibrosis bronchial epithelial cells","volume":"10","author":"Dauletbaev","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcf.2026.07.1985_bib0018","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3389\/fimmu.2020.01327","article-title":"Rhinovirus infection drives complex host airway molecular responses in children with cystic fibrosis","volume":"11","author":"Ling","year":"2020","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.jcf.2026.07.1985_bib0019","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1165\/rcmb.2024-0213OC","article-title":"Distinct responses of cystic fibrosis epithelial cells to SARS-CoV-2 and Influenza A virus","volume":"72","author":"Pagani","year":"2025","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"10.1016\/j.jcf.2026.07.1985_bib0020","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jcf.2015.10.013","article-title":"Interferon response of the cystic fibrosis bronchial epithelium to major and minor group rhinovirus infection","volume":"15","author":"Schogler","year":"2016","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.jcf.2026.07.1985_bib0021","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jcf.2020.08.012","article-title":"Immune response of polarized cystic fibrosis airway epithelial cells infected with Influenza A virus","volume":"20","author":"Sofoluwe","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"6","key":"10.1016\/j.jcf.2026.07.1985_bib0022","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1165\/rcmb.2010-0368OC","article-title":"Innate inflammatory responses of pediatric cystic fibrosis airway epithelial cells: effects of nonviral and viral stimulation","volume":"44","author":"Sutanto","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"9","key":"10.1016\/j.jcf.2026.07.1985_bib0023","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1089\/jir.2006.26.609","article-title":"Cystic fibrosis and normal human airway epithelial cell response to influenza a viral infection","volume":"26","author":"Xu","year":"2006","journal-title":"J Interferon Cytokine Res"},{"issue":"5","key":"10.1016\/j.jcf.2026.07.1985_bib0024","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S1074-7613(03)00114-6","article-title":"Impaired innate host defense causes susceptibility to respiratory virus infections in cystic fibrosis","volume":"18","author":"Zheng","year":"2003","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.jcf.2026.07.1985_bib0025","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1172\/JCI34773","article-title":"Production of CFTR-null and CFTR-DeltaF508 heterozygous pigs by adeno-associated virus-mediated gene targeting and somatic cell nuclear transfer","volume":"118","author":"Rogers","year":"2008","journal-title":"J Clin Invest"},{"issue":"5897","key":"10.1016\/j.jcf.2026.07.1985_bib0026","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1126\/science.1163600","article-title":"Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs","volume":"321","author":"Rogers","year":"2008","journal-title":"Science"},{"issue":"6198","key":"10.1016\/j.jcf.2026.07.1985_bib0027","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.1255825","article-title":"Impaired mucus detachment disrupts mucociliary transport in a piglet model of cystic fibrosis","volume":"345","author":"Hoegger","year":"2014","journal-title":"Science"},{"issue":"7405","key":"10.1016\/j.jcf.2026.07.1985_bib0028","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature11130","article-title":"Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung","volume":"487","author":"Pezzulo","year":"2012","journal-title":"Nature"},{"issue":"29","key":"10.1016\/j.jcf.2026.07.1985_bib0029","doi-asserted-by":"crossref","first-page":"29ra31","DOI":"10.1126\/scitranslmed.3000928","article-title":"Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth","volume":"2","author":"Stoltz","year":"2010","journal-title":"Sci Transl Med"},{"issue":"Suppl 3","key":"10.1016\/j.jcf.2026.07.1985_bib0030","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.1513\/AnnalsATS.201805-308AW","article-title":"Mucociliary transport in healthy and cystic fibrosis pig airways","volume":"15","author":"Xie","year":"2018","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jcf.2026.07.1985_bib0031","doi-asserted-by":"crossref","DOI":"10.1002\/9780471729259.mc15g01s29","article-title":"Influenza: propagation, quantification, and storage","author":"Balish","year":"2013","journal-title":"Curr Protoc Microbiol"},{"issue":"1\u20132","key":"10.1016\/j.jcf.2026.07.1985_bib0032","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.vetmic.2014.12.021","article-title":"Comparative virulence of wild-type H1N1pdm09 influenza A isolates in swine","volume":"176","author":"Henningson","year":"2015","journal-title":"Vet Microbiol"},{"issue":"22","key":"10.1016\/j.jcf.2026.07.1985_bib0033","doi-asserted-by":"crossref","first-page":"11626","DOI":"10.1128\/JVI.05705-11","article-title":"2009 pandemic H1N1 influenza virus causes disease and upregulation of genes related to inflammatory and immune responses, cell death, and lipid metabolism in pigs","volume":"85","author":"Ma","year":"2011","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.jcf.2026.07.1985_bib0034","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1165\/ajrcmb.13.3.7544594","article-title":"Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis","volume":"13","author":"Bonfield","year":"1995","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"6 Pt 1","key":"10.1016\/j.jcf.2026.07.1985_bib0035","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1164\/ajrccm.152.6.8520783","article-title":"Inflammatory cytokines in cystic fibrosis lungs","volume":"152","author":"Bonfield","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.jcf.2026.07.1985_bib0036","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.4049\/jimmunol.168.4.1903","article-title":"Functional IL-10 deficiency in the lung of cystic fibrosis (cftr(-\/-)) and IL-10 knockout mice causes increased expression and function of B7 costimulatory molecules on alveolar macrophages","volume":"168","author":"Soltys","year":"2002","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.jcf.2026.07.1985_bib0037","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/thx.47.2.109","article-title":"Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark","volume":"47","author":"Johansen","year":"1992","journal-title":"Thorax"},{"issue":"782","key":"10.1016\/j.jcf.2026.07.1985_bib0038","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adk9145","article-title":"Perinatal dysfunction of innate immunity in cystic fibrosis","volume":"17","author":"Jaudas","year":"2025","journal-title":"Sci Transl Med"},{"issue":"7","key":"10.1016\/j.jcf.2026.07.1985_bib0039","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1164\/rccm.201510-2112OC","article-title":"Newborn cystic fibrosis pigs have a blunted early response to an inflammatory stimulus","volume":"194","author":"Bartlett","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.jcf.2026.07.1985_bib0040","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s10020-025-01266-7","article-title":"Cellular imbalance in proximal and distal lung of CFTR(-\/-) sheep in utero and at birth","volume":"31","author":"Leir","year":"2025","journal-title":"Mol Med"},{"issue":"4","key":"10.1016\/j.jcf.2026.07.1985_bib0041","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jcf.2017.03.007","article-title":"Monocyte derived macrophages from CF pigs exhibit increased inflammatory responses at birth","volume":"16","author":"Paemka","year":"2017","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.jcf.2026.07.1985_bib0042","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1165\/rcmb.2008-0170OC","article-title":"Macrophages directly contribute to the exaggerated inflammatory response in cystic fibrosis transmembrane conductance regulator-\/- mice","volume":"40","author":"Bruscia","year":"2009","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"9","key":"10.1016\/j.jcf.2026.07.1985_bib0043","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.191098","article-title":"CFTR negatively reprograms Th2 cell responses, and CFTR potentiation restrains allergic airway inflammation","volume":"10","author":"Rusznak","year":"2025","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.jcf.2026.07.1985_bib0044","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1165\/rcmb.2018-0304OC","article-title":"Airway surface liquid has innate antiviral activity that is reduced in cystic fibrosis","volume":"62","author":"Berkebile","year":"2020","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"2","key":"10.1016\/j.jcf.2026.07.1985_bib0045","doi-asserted-by":"crossref","first-page":"931","DOI":"10.4049\/jimmunol.171.2.931","article-title":"Inactivation of human beta-defensins 2 and 3 by elastolytic cathepsins","volume":"171","author":"Taggart","year":"2003","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.jcf.2026.07.1985_bib0046","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1164\/rccm.201311-1986OC","article-title":"miR-31 dysregulation in cystic fibrosis airways contributes to increased pulmonary cathepsin S production","volume":"190","author":"Weldon","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"17","key":"10.1016\/j.jcf.2026.07.1985_bib0047","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1021\/acs.biochem.5b00231","article-title":"Antimicrobial peptide LL-37 is both a substrate of cathepsins S and K and a selective inhibitor of cathepsin L","volume":"54","author":"Andrault","year":"2015","journal-title":"Biochemistry"},{"issue":"8","key":"10.1016\/j.jcf.2026.07.1985_bib0048","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.biocel.2013.05.018","article-title":"Specific cleavage of the lung surfactant protein A by human cathepsin S may impair its antibacterial properties","volume":"45","author":"Lecaille","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"issue":"7","key":"10.1016\/j.jcf.2026.07.1985_bib0049","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1086\/423821","article-title":"Loss of microbicidal activity and increased formation of biofilm due to decreased lactoferrin activity in patients with cystic fibrosis","volume":"190","author":"Rogan","year":"2004","journal-title":"J Infect Dis"},{"issue":"36","key":"10.1016\/j.jcf.2026.07.1985_bib0050","doi-asserted-by":"crossref","first-page":"33345","DOI":"10.1074\/jbc.M103220200","article-title":"Cathepsin B, L, and S cleave and inactivate secretory leucoprotease inhibitor","volume":"276","author":"Taggart","year":"2001","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.jcf.2026.07.1985_bib0051","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1172\/JCI83922","article-title":"Acidic pH increases airway surface liquid viscosity in cystic fibrosis","volume":"126","author":"Tang","year":"2016","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.jcf.2026.07.1985_bib0052","doi-asserted-by":"crossref","first-page":"L670","DOI":"10.1152\/ajplung.00422.2015","article-title":"Electrolyte transport properties in distal small airways from cystic fibrosis pigs with implications for host defense","volume":"310","author":"Li","year":"2016","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"13","key":"10.1016\/j.jcf.2026.07.1985_bib0053","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2121731119","article-title":"Elastic mucus strands impair mucociliary clearance in cystic fibrosis pigs","volume":"119","author":"Pino-Argumedo","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.jcf.2026.07.1985_bib0054","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s10439-013-0955-7","article-title":"Early airway structural changes in cystic fibrosis pigs as a determinant of particle distribution and deposition","volume":"42","author":"Awadalla","year":"2014","journal-title":"Ann Biomed Eng"},{"issue":"10","key":"10.1016\/j.jcf.2026.07.1985_bib0055","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1164\/rccm.201004-0643OC","article-title":"Loss of cystic fibrosis transmembrane conductance regulator function produces abnormalities in tracheal development in neonatal pigs and young children","volume":"182","author":"Meyerholz","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"13","key":"10.1016\/j.jcf.2026.07.1985_bib0056","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1113\/jphysiol.2008.150763","article-title":"Congenital tracheal malformation in cystic fibrosis transmembrane conductance regulator-deficient mice","volume":"586","author":"Bonvin","year":"2008","journal-title":"J Physiol"},{"issue":"9","key":"10.1016\/j.jcf.2026.07.1985_bib0057","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1002\/ppul.26550","article-title":"Prevalence of tracheobronchomalacia is higher than previously reported in children with cystic fibrosis","volume":"58","author":"Depiazzi","year":"2023","journal-title":"Pediatr Pulmonol"},{"issue":"10","key":"10.1016\/j.jcf.2026.07.1985_bib0058","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1002\/lary.25255","article-title":"Sonographic evidence of abnormal tracheal cartilage ring structure in cystic fibrosis","volume":"125","author":"Diwakar","year":"2015","journal-title":"Laryngoscope"},{"issue":"3","key":"10.1016\/j.jcf.2026.07.1985_bib0059","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1073\/pnas.1914912117","article-title":"Cystic fibrosis carriers are at increased risk for a wide range of cystic fibrosis-related conditions","volume":"117","author":"Miller","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.jcf.2026.07.1985_bib0060","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae024","article-title":"Cystic fibrosis carrier states are associated with more severe cases of bronchiectasis","volume":"11","author":"Miller","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"11","key":"10.1016\/j.jcf.2026.07.1985_bib0061","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaf642","article-title":"The increased risk for postinfluenza pneumonia among cystic fibrosis carriers-a population-based study","volume":"12","author":"Miller","year":"2025","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"10.1016\/j.jcf.2026.07.1985_bib0062","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jcf.2020.07.004","article-title":"Ivacaftor or lumacaftor\/ivacaftor treatment does not alter the core CF airway epithelial gene response to rhinovirus","volume":"20","author":"De Jong","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.jcf.2026.07.1985_bib0063","doi-asserted-by":"crossref","first-page":"e221","DOI":"10.1016\/j.jcf.2022.06.006","article-title":"Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: a global observational study","volume":"21","author":"Carr","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.jcf.2026.07.1985_bib0064","doi-asserted-by":"crossref","first-page":"L344","DOI":"10.1152\/ajplung.00223.2025","article-title":"Genetic and chemical correction of cystic fibrosis reduces airway susceptibility to SARS-CoV-2","volume":"330","author":"Rollins","year":"2026","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"11","key":"10.1016\/j.jcf.2026.07.1985_bib0065","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1164\/rccm.202310-1836OC","article-title":"Pharmacological improvement of Cystic fibrosis transmembrane conductance regulator function rescues airway epithelial homeostasis and host defense in children with Cystic Fibrosis","volume":"209","author":"Loske","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.jcf.2026.07.1985_bib0066","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/ppul.26898","article-title":"Effects of highly effective modulator therapy on the dynamics of the respiratory mucosal environment and inflammatory response in cystic fibrosis","volume":"59","author":"Atteih","year":"2024","journal-title":"Pediatr Pulmonol"},{"issue":"10","key":"10.1016\/j.jcf.2026.07.1985_bib0067","doi-asserted-by":"crossref","first-page":"5521","DOI":"10.1007\/s11010-025-05331-x","article-title":"Elexacaftor\/tezacaftor\/ivacaftor (ETI) therapy modifies the expression of interferon beta and inflammatory genes in the airways of adult patients with cystic fibrosis: a pilot study","volume":"480","author":"Bitossi","year":"2025","journal-title":"Mol Cell Biochem"},{"issue":"6","key":"10.1016\/j.jcf.2026.07.1985_bib0068","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00150-2025","article-title":"Reduction of systemic inflammation by elexacaftor\/tezacaftor\/ivacaftor correlates with lung function improvement in cystic fibrosis","volume":"66","author":"Halle","year":"2025","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.jcf.2026.07.1985_bib0069","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12931-026-03494-9","article-title":"Modulation of immune responses by elexacaftor\/tezacaftor\/ivacaftor therapy in cystic fibrosis: data from a compassionate use program","volume":"27","author":"Lucca","year":"2026","journal-title":"Respir Res"},{"issue":"9","key":"10.1016\/j.jcf.2026.07.1985_bib0070","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1136\/thorax-2024-222242","article-title":"Effect of elexacaftor\/tezacaftor\/ivacaftor on systemic inflammation in cystic fibrosis","volume":"80","author":"Maher","year":"2025","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.jcf.2026.07.1985_bib0071","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/ppul.26261","article-title":"Impact of elexacaftor-tezacaftor-ivacaftor on bacterial colonization and inflammatory responses in cystic fibrosis","volume":"58","author":"Sheikh","year":"2023","journal-title":"Pediatr Pulmonol"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156919932603660X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156919932603660X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T05:07:48Z","timestamp":1786079268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156919932603660X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":71,"alternative-id":["S156919932603660X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2026.07.1985","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiviral defenses are diminished at birth in cystic fibrosis pig airways","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2026.07.1985","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}